Member access

4-Traders Homepage  >  Shares  >  SHENZHEN STOCK EXCHANGE  >  Beijing SL Pharmaceutical Co Ltd    002038   CNE000001L31

No quotes available
-- CNY   --.--%
2014 BEIJING SL PHAR : H1 Net Up 22%
2014 BEIJING SL PHAR : SL Pharmaceutical 2013 Net Up 20.04%
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Beijing SL Pharmaceutical
Produces and supplies pharmaceutical products

Beijing SL Pharmaceutical Co. Ltd. engages in the development and marketing gene engineering drugs.

Its products include Li Sheng Su, a recombinant human Granulocyte Colony-stimulating Factor (rhG-CSF) injection; Mai Ge Er, a recombinant human Interleukin-11 (rhIL-11) injection; and Xin Ji Er, a recombinant human Ala Interleukin-2 (Ala IL-2) injection.

The company was founded by Ming Bo Xu in December 1994 and is headquartered in Beijing, China.

Number of employees : 637 persons.
Sales per Businesses
20122013Delta
CNY (in Million)%CNY (in Million)%
Biochemical Medicine822.9081.8%981.0284.5% +16.12%
Chemistry Medicine128.9412.8%131.5311.3% +1.97%
Other Service Income55.185.5%35.003% -57.68%
Other--14.231.2%-
Sales per Regions
20122013Delta
CNY (in Million)%CNY (in Million)%
China1,006100%1,161100% +13.33%
Managers
NameAgeSinceTitle
Mingbo Xu, PhD51-Chairman & President
Anjing Lu58-Chairman-Supervisory Board
Wenying Xi52-Chief Financial Officer
Yu Lin Chen70-Director
Xiu Jiang Wen38-Director-Supervisory Board
Qing Jun Ma79-Independent Director
Su Yan Wei, CPA63-Independent Director
Ming Xi Zhang, CPA452007Independent Director
Shujie Liang49-Board Secretary
Yong Bo Wang40-Vice President
Shareholders
NameShares%
Xinxiang State Owned Asset Sup. & Adm. Commssion 96,643,729 25.6%
Mingbo Xu, PhD 25,743,501 6.82%
China Resources SZITIC Trust Co., Ltd. 13,230,039 3.51%
E Fund Management Co., Ltd. 8,700,000 2.30%
Harvest Fund Management Co., Ltd. 8,661,037 2.29%
Bin Wang 5,565,800 1.47%
Penghua Fund Management Co., Ltd. 4,880,220 1.29%
China International Fund Management Co., Ltd. 4,510,773 1.20%
AEGON-INDUSTRIAL Fund Management Co., Ltd. 3,986,028 1.06%
Dacheng Fund Management Co., Ltd. 3,862,985 1.02%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
INTERCEPT PHARMAC..
RECEPTOS INC
JUNO THERAPEUTICS..
-
HUALAN BIOLOGICAL..
GENMAB A/S
BLUEBIRD BIO INC
TONGHUA DONGBAO P..
BEIJING SL PHARMA..
DYAX CORP.
AGIOS PHARMACEUTI..
NEUROCRINE BIOSCI..
AUSPEX PHARMACEUT..
-
CLOVIS ONCOLOGY I..
KITE PHARMA INC
TESARO INC
CHINA BIOLOGIC PR..
ULTRAGENYX PHARMA..
-
Sector Biotechnology & Medical Research
Beijing SL Pharmaceutical : Connections
Accounting Society of China
Beijing Jurassic Software Co., Ltd.
Beijing Institute of Technology
Beijing Society of Biotechnology
Xinxiang Bailu Chemical Fiber Group Co. Ltd.
Chinese Society of Biotechnology
Company contact information
Beijing SL Pharmaceutical Co., Ltd.
9 Zhongyuan Road
Bada High Development District
Beijing 100041

Phone : +86.10.8879.9370
Fax : +86.10.8879.5883
Web : www.slpharm.com.cn
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF